Spatial Genomics & Transcriptomics Market Size, Share, Industry Analysis, Trends, Growth, Forecasts, 2032

Spatial Genomics & Transcriptomics Market Insights

According to the report published by Zion Market Research, the global Spatial Genomics & Transcriptomics Market size was valued at USD 265.93 Million in 2023 and is predicted to reach USD 891.09 Million by the end of 2032. The market is expected to grow with a CAGR of 14.38% during the forecast period. The report analyzes the global Spatial Genomics & Transcriptomics Market's growth drivers, restraints, and impact on demand during the forecast period. It will also help navigate and explore the arising opportunities in the Spatial Genomics & Transcriptomics industry.

Request Free Sample

Global Spatial Genomics & Transcriptomics Market: Overview

The technological advancements in medical science and technology are been revolutionizing the healthcare sector. The technology is used to resolve RNA seq-data spatially and thereby mRNAs in an individual’s tissue sections. The data that is been generated by the technology of spatial transcriptomics enables to choose the gene of interest and display the spatially resolved expression on the section of the original tissue. As all the mRNAs are captured, the researchers or scientists are not a constraint to visualize a single gene. Any number of genes can be chosen in combination to view and analyze together.

Global Spatial Genomics & Transcriptomics Market: Growth Factors

Increase in biomarker identification using spatial omics, rise in focus of biopharmaceuticals & biotech companies for novel drug discovery & development programs, and rise in adoption of spatial genomics & transcriptomics by startups as well as small companies are fostering the growth of the global spatial genomics & transcriptomics market. The information obtained from the genetic components like chromatin network, RNA, and DNA within the cells is critical to assess homeostasis, cellular function, and gene expression changes and is correlated to disease progression and states.

However, there is a lack of information regarding localization, differentiation, and spatial organization that exists at the transcriptomic and genomic level that is present in the tissue and cells. Using conventional tools, such information is not captured effectively and thus vital information regarding cellular machinery is been lost in translation. To fulfill this gap of knowledge spatial genomics & transcriptomics are evolving rapidly in the areas of the research. Thus, there is a huge demand for spatial genomics & transcriptomics which in turn is boosting the growth of the global market. Moreover, the growing demand for spatial genomics & transcriptomics in clinical development and research in areas like cardiovascular, neurology, infectious disease, and immune-oncology are also contributing to the growth of the market.

Furthermore, technological advancements in the field with the launch of fluorescence in situ hybridization (FISH) and multiplexed, high-throughput systems will lead to great opportunities in the growth of the global spatial genomics & transcriptomics market. However, a lack of skilled professionals may hamper the growth of the global spatial genomics & transcriptomics market.

The Covid-19 pandemic has a moderate impact on the global spatial genomics & transcriptomics market. Initially, with the outbreak of the Covid-19, the strict rules imposed by the government of strict lockdown and restriction on the movement led to disruption in the supply chain and unavailability of the workers. These factors have affected the availability of reagents, instruments, and consumables. In addition to this research and academic institutes have been shut down which also impacted the demand for analysis using spatial genomics & transcriptomics. On the other hand, in the upcoming years, the global spatial genomics & transcriptomics market is estimated to grow at a healthy rate due to the rise in biomarker identification and its use in drug discovery and development programs.

Request Free Sample

Global Spatial Genomics & Transcriptomics Market: Segmentation

The global spatial genomics & transcriptomics market is bifurcated into application, technique, end-user, and region.

Based on the application, the global spatial genomics & transcriptomics market is divided into drug discovery & development and translational research.

Based on the technique, the global market is split into spatial genomic analysis, spatial transcriptomics, and product.

The end-user segment is categorized into pharmaceutical & biotech companies, contract research organizations, and academic & research institutes.

Spatial Genomics & Transcriptomics Market: Report Scope

Global Spatial Genomics & Transcriptomics Market: Regional Analysis

North America is predicted to account for the maximum share in the global spatial genomics & transcriptomics market. Factors such as rapid adoption of advanced technology, growing demand in research & academic institutes, and the presence of key players are contributing to the growth of the market in this region. Europe is the second-largest market and this is attributed to the presence of well-established healthcare infrastructure and emerging players. The market in Asia Pacific is estimated to grow at a faster pace due to the rise in drug discovery and development programs as well as an increase in a number of contract research organizations offering services to the pharmaceutical as well as research institutes.

Global Spatial Genomics & Transcriptomics Market: Competitive Players

• S2 Genomics
• Fluidigm Corporation
• Illumina
• NanoString Technologies
• ReadCoor
• Bio-Techne
• 10X Genomics
• Horizon Discovery Group plc
• Seven Bridges Genomics
• Dovetail Genomics

are some of the major players operating in the global spatial genomics & transcriptomics market.

The Global Spatial Genomics & Transcriptomics Market is segmented as follows:
    
By application 

• drug discovery & development
• translational research 

By technique 

• spatial genomic analysis 
• spatial transcriptomics
• product

By end-user 

• pharmaceutical & biotech companies
• contract research organizations
• academic & research institutes

Global Spatial Genomics & Transcriptomics Market: Regional Segment Analysis

• North America
  • The U.S.
  • Canada
• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa

What Reports Provides

• Full in-depth analysis of the parent market
• Important changes in market dynamics
• Segmentation details of the market
• Former, on-going, and projected market analysis in terms of volume and value
• Assessment of niche industry developments
• Market share analysis
• Key strategies of major players
• Emerging segments and regional markets
• Testimonials to companies in order to fortify their foothold in the market.